SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $686,472 | +1.6% | 5,663 | -4.0% | 0.00% | 0.0% |
| Q2 2023 | $675,439 | -27.1% | 5,898 | -12.3% | 0.00% | -25.0% |
| Q1 2023 | $926,769 | +20.4% | 6,724 | +13.2% | 0.00% | 0.0% |
| Q4 2022 | $769,835 | +83.7% | 5,941 | +56.8% | 0.00% | +100.0% |
| Q3 2022 | $419,000 | +61.2% | 3,788 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $260,000 | -3.0% | 3,471 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $268,000 | -11.3% | 3,427 | +2.3% | 0.00% | 0.0% |
| Q4 2021 | $302,000 | -45.4% | 3,350 | -44.0% | 0.00% | -60.0% |
| Q3 2021 | $553,000 | +7.2% | 5,977 | -10.0% | 0.01% | 0.0% |
| Q2 2021 | $516,000 | +2.6% | 6,642 | -1.5% | 0.01% | 0.0% |
| Q1 2021 | $503,000 | -57.2% | 6,743 | -2.1% | 0.01% | -68.8% |
| Q4 2020 | $1,174,000 | +19.3% | 6,885 | -1.0% | 0.02% | 0.0% |
| Q3 2020 | $984,000 | -17.2% | 6,955 | -3.0% | 0.02% | -20.0% |
| Q2 2020 | $1,188,000 | +12.9% | 7,170 | -36.6% | 0.02% | -13.0% |
| Q1 2020 | $1,052,000 | -32.5% | 11,315 | -6.3% | 0.02% | -8.0% |
| Q4 2019 | $1,559,000 | – | 12,080 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,999,453 | $413,414,607 | 13.31% |
| Casdin Capital, LLC | 1,160,000 | $159,882,800 | 13.17% |
| Ikarian Capital, LLC | 271,300 | $37,393,279 | 8.48% |
| Avoro Capital Advisors LLC | 3,650,000 | $503,079,500 | 7.46% |
| Evolutionary Tree Capital Management, LLC | 36,190 | $4,988,068 | 6.91% |
| Finepoint Capital LP | 122,757 | $16,919,597 | 6.46% |
| Ikarian Capital, LLC | 205,400 | $28,310,282 | 6.42% |
| Boxer Capital, LLC | 775,000 | $106,818 | 5.25% |
| Ghost Tree Capital, LLC | 125,000 | $17,229,000 | 5.09% |
| Logos Global Management LP | 220,000 | $30,322,600 | 4.34% |